Psoriasis Therapy can Reduce Coronary Inflammation

Psoriasis therapy reduces coronary inflammation, which can be measured by an imaging biomarker called perivascular fat attenuation index (FAI). Psoriasis therapy appreciably reduces the risk of fatal cardiac events such as heart attack and stroke.
Email bookmark
Font : A-A+

Related Links